Hemab Therapeutics Holdings, Inc. (COAG)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
32. 52
+2.58
+8.6172%
$
1.39B Market Cap
- P/E Ratio
- Div Yield
478,279 Volume
- Eps
$ 29.94
Previous Close 
Want to track COAG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hemab Therapeutics Holdings, Inc. (COAG) Statistics
Valuation metrics
Market Cap 1.39B
Enterprise value 1.24B
Trailing P/E (ttm) -24.14
Forward P/E -
PEG ratio -0.24
Price/Sales (ttm) -
Price/Book (mrq) 2.1
Enterprise Value/Revenue -
Enterprise Value/EBITDA -25.04
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 619.1K
Average volume (90 days) 847.5K
Price summary
52-Week low 23
52-Week high 55.42
Beta -
50-Day moving average 36.93
200-Day moving average 31.5
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.1%
Return on equity -0.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.56
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 35.85%
Book value per share (mrq) 15.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
